sanofi信息详情
赛诺菲（公司名）
batture sand───网砂
palo santo───圣树
consanguineal kinship───血缘关系
old san juan───圣胡安
courtesan beijing───北京妓女
thousands numbers───数千个数字
SantaC aus───桑塔克来自
darkner sans───没有帐号？
sanitary meaning───卫生意义
sanctified zealot───神圣的狂热者
France's Sanofi-Aventis is carrying out large clinical trials of an oral drug called teriflunomide.───法国制药公司赛诺菲-安万特也在就一种口服药物特立氟胺开展大型临床试验。
Buy stock in Sanofi.───购买赛诺菲的股票。
Visitors must be accompanied by someone from Sanofi.───访客必须在赛诺菲·安万特公司员工的陪同下才可以进入。
Sanofi spokeswoman Emmy Tsui said the company was "committed to the safe and effective use of Eligard" and was reviewing the FDA request.───赛诺菲发言人艾美.奖翠表示，该公司正按照FDA的要求，“致力于醋酸亮丙瑞林使用的安全性和有效性研究”。
Sanofi said the acquisition chase is getting more competitive as industry players face the same set of problems.───赛诺菲表示，由于制药业厂商面临同样的问题，收购竞逐变得越来越激烈。
Just yesterday, Sanofi-Aventis said it was abandoning its drug Acomplia, which had been approved in Europe to treat obesity.───就在昨天，赛诺菲安万特宣布放弃其药物Acomplia，其已获欧洲批准用于治疗肥胖症。
Sanofi and other drugmakers annually produce about 300 million doses of seasonal flu vaccines, the kind used for annual flu shots.───赛诺菲和其它的制药企业每年生产3亿支季节性感冒疫苗--那种每年注射一次的疫苗。
WHO officials "are convinced that the seasonal influenza vaccine is just as important, " the Sanofi Pasteur spokesman says.───世卫组织官员确信，”季节性流感疫苗也是同样重要的，“赛诺菲巴斯德的这位发言人说。
Analysts believe Sanofi could be waiting for a final safety review for TroVax, due in the next few months.───分析家相信赛诺菲在等待关于TroVax的最终安全评估，该评估将在近几个月公布。
In 2007, HHS awarded Sanofi a $77.4 million contract to retrofit that site for preparedness for a flu pandemic.
Indeed, a spokesman for Sanofi's own vaccine unit, Sanofi Pasteur, says it could probably produce both types "in parallel" for a time, before ramping up full-scale production of a swine-flu vaccine.
Earlier on Monday, the two companies said in a regulatory filing that they had entered into a nondisclosure agreement, allowing Genzyme to open its books to Sanofi.
The drug companies Pfizer, Sanofi - Aventis and Nektar Therapeutics developed it.
Today, sanofi pasteur reinvests some 17 percent of its revenues into research and development.